<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>
<title>8 Antibiotics - Dihydrofolate reductase inhibitors</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
		<link href="../sgStyles2.css" rel="stylesheet" type="text/css">
		<csimport user="../../../pharmTox.data/InDesignPackages/8 antibiotics/story_1052.incd" occur="22">
			
		</csimport>
	</head>

<body>
	<a id="top"></a>
	<div id="text">
		<div id="sumbox">
		
			<div id="drugbox">
			<strong>commonly used drugs</strong><br>
					co-trimoxazole (sulphamethoxazole &amp; trimethoprim)<br>
					co-trimazine (sulphadiazine &amp; trimethoprim)
			</div>
		</div>

<p class="titleSG">Dihydrofolate reductase inhibitors</p>
		
		<input type="Button" value="Previous Page" onClick="history.go(-1)">
		<p><a href="abNASynIndx.html">mechanism diagram</a></p>
				
				
<csobj csref="../../../pharmTox.data/InDesignPackages/8 antibiotics/story_1052.incd" h="1214" occur="22" t="Component" g="incopy_default" s="">
			<p class="ParBodytext"><span style="font-weight: bold; ">Trimethoprim</span> is a diaminopyrimidine analogue of para aminobenzoic acid. A very similar drug, <span style="font-weight: bold; ">baquiloprim</span>, is also used in cattle and pigs because trimethoprim has a short half life in these species. They are nearly always used in combination with sulphonamides (potentiated sulphonamides).</p>
			<p class="ParBodytext"></p>
			<p class="ParSubhead2">Mechanism of action</p>
			<p class="ParBodytext">Trimethoprim acts by inhibiting the enzyme dihydrofolate reductase. This results in failure to reduce dihydrofolate to tetrahydrofolate, thereby blocking pyrimidine synthesis and potentiating the effects of sulphonamides.</p>
			<p class="ParBodytext"></p>
			<p class="ParSubhead2">Spectrum of activity</p>
			<p class="ParBodytext">Trimethoprim has a similar spectrum of activity as sulphonamides. The two agents are probably synergistic in most circumstances. Trimethoprim is used alone in urinary infections in people, where it appears that sulphonamides do not contribute to its effect.</p>
			<p class="ParBodytext"></p>
			<p class="ParSubhead2">Resistance</p>
			<p class="ParBodytext">Plasmids encoding trimethoprim resistant dihydrofolate reductases can be passed on and become incorporated in the chromosomal DNA. Some bacteria just overproduce dihydrofolate reductase. Cell wall permeability to trimethoprim may also reduce and some bacteria have learned to rely on exogenous thymine and thymidine as mammals do.</p>
			<p class="ParBodytext">Clinically, resistance exists but is not a huge problem.</p>
			<p class="ParBodytext"></p>
			<p class="ParSubhead2">Toxicity</p>
			<p class="ParBodytext">Blood dyscrasias (anaemia) occur rarely and are usually reversible by stopping trimethoprim or giving folate. Trimethoprim may cause an increase in serum creatinine through inhibition of renal secretion. Several cases of hypersensitivity in Dobermanns and Great Danes have occurred with polyarthritis, pyrexia, anorexia and depression. This was probably caused by the sulphonamide component of the mixture.</p>
			<p class="ParBodytext"></p>
			<p class="ParBodytext">All the side effects of sulphonamides can occur with potentiated sulphonamides as well.</p>
			<p class="ParBodytext"></p>
			<p class="ParSubhead2">Pharmacokinetics</p>
			<p class="ParBodytext">Trimethoprim is usually administered with sulphamethoxazole (co-trimoxazole) or sulphadiazine (co-trimazine) at a fixed dose ratio of 1:5. The pharmacokinetics of trimethoprim and sulphamethoxazole are closely matched when given independently in most species. However, trimethoprim tends to slow the absorption of sulphamethoxazole. These kinetic interactions vary between species. High levels are areached in the urine and CNS.</p>
			<p class="ParBodytext"></p>
			<p class="ParBodytext">Trimethoprim is more slowly eliminated than short acting sulphonamides in most species. Therefore the combination with sulphamethoxazole seems more rational, especially in the dog where acetylation of sulphamethoxazole is not a problem. The half life of trimethoprim in cattle is about 30 min, so baquiloprim, with a half life of 10 hours, seems a more rational choice.</p>
			<p class="ParBodytext"></p>
			<p class="ParSubhead2">Similar drugs</p>
			<p class="ParBodytext">A variety of dihydrofolate reductase inhibitors are used against protozoa. <span style="font-weight: bold; ">Pyrimethamine</span> is more specific for protozoal dihydrofolate reductase and was commonly used for malaria in man, and occasionally for <span style="font-style: italic; ">Toxoplasma </span>or similar organisms in animals. <span style="font-weight: bold; ">Methotrexate</span> is more specific for mammalian dihydrofolate reductase and is used as an anticancer drug (qv).</p>
			<p class="ParBodytext"></p>
			<p class="ParBodytext">Current research is concentrating on dihydrofolate reductase inhibitors which are more specific for Gram positives, specifically MRSA. There are a number of promising drugs coming along.</p>
		</csobj>

		
		<p>back to <a href="abNASynIndx.html">nucleic acid synthesis inhibitors</a></p>
		<table width="90%" border="0" align="center">
  <tr>
				<td class="titleSG"><a href="abIndex.html" class="aTitle">8 Antibiotics index</a></td>
			</tr>
</table>
		<br>
<table width="90%" border="0" align="center">
  <tr align="center">
    <td>    <a href="../../indexpharm.html"><img src="../../PharmBut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../../toxSite/indexTox.html"><img src="../../ToxBut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../indexSG.html"><img src="../../SGbut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../../lectureSite/indexLec.html"><img src="../../LecBut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../../formSite/Aform.html" target="_blank"><img src="../../FormBut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../../casesSite/indexCases.html"><img src="../../CaseBut.gif" width="100" height="21" border="0"></a></td>
  </tr>
</table>
<br>
<table width="90%" border="0" align="center" cellpadding="2" cellspacing="0">
  <tr bgcolor="#FFFFFF">
    <td width="50%" class="commonname"><img src="../../pharmBits/images/mulogo.gif" width="170" height="25"></td>
    <td width="50%" align="right" class="references"><div align="right">copyright
        Massey University</div>
    </td>
  </tr>
</table>
<p>&nbsp;</p>
</div>
		<div id="gototop"><a href="#top"><b>top</b></a></div>

</div>
</body>
</html>
